Elite Health Systems Inc. (USNU)
OTCMKTS · Delayed Price · Currency is USD
0.8600
+0.0100 (1.18%)
At close: May 16, 2025

Elite Health Systems Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
----1.063.17
Upgrade
Revenue Growth (YoY)
-----66.56%3.36%
Upgrade
Cost of Revenue
----0.090.36
Upgrade
Gross Profit
----0.982.81
Upgrade
Selling, General & Admin
1.741.790.771.071.061.2
Upgrade
Operating Expenses
1.741.790.771.071.061.2
Upgrade
Operating Income
-1.74-1.79-0.77-1.07-0.091.62
Upgrade
Interest Expense
---0--0-0.03
Upgrade
Interest & Investment Income
0.010.01--0.010.08
Upgrade
Earnings From Equity Investments
-0.44-0.43-0.05-0.15-0.47-0.81
Upgrade
EBT Excluding Unusual Items
-2.17-2.22-0.82-1.22-0.550.86
Upgrade
Impairment of Goodwill
----0.32--
Upgrade
Pretax Income
-2.17-2.22-0.82-1.53-0.550.86
Upgrade
Income Tax Expense
--0.16-0.040.420.32
Upgrade
Earnings From Continuing Operations
-2.17-2.06-0.82-1.57-0.970.53
Upgrade
Minority Interest in Earnings
---0.240.09-
Upgrade
Net Income
-2.17-2.06-0.82-1.34-0.880.53
Upgrade
Net Income to Common
-2.17-2.06-0.82-1.34-0.880.53
Upgrade
Net Income Growth
-----275.35%
Upgrade
Shares Outstanding (Basic)
18159888
Upgrade
Shares Outstanding (Diluted)
18159888
Upgrade
Shares Change (YoY)
71.60%65.62%18.40%0.64%--
Upgrade
EPS (Basic)
-0.12-0.13-0.09-0.17-0.110.07
Upgrade
EPS (Diluted)
-0.12-0.13-0.09-0.17-0.110.07
Upgrade
EPS Growth
-----275.36%
Upgrade
Free Cash Flow
-1.35-1.52-0.89-1.410.171.12
Upgrade
Free Cash Flow Per Share
-0.08-0.10-0.10-0.180.020.14
Upgrade
Gross Margin
----91.89%88.62%
Upgrade
Operating Margin
-----8.29%50.90%
Upgrade
Profit Margin
-----83.03%16.80%
Upgrade
Free Cash Flow Margin
----16.40%35.20%
Upgrade
EBIT
-1.74-1.79-0.77-1.07-0.091.62
Upgrade
EBIT Margin
-----8.29%50.90%
Upgrade
Effective Tax Rate
-----37.73%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.